Chokshi & Queen Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
1,045
+280
+37% +$286K 0.58% 21
2026
Q1
$704K Buy
765
+127
+20% +$129K 0.38% 31
2025
Q4
$686K Hold
638
0.36% 31
2025
Q3
$487K Sell
638
-398
-38% -$296K 0.26% 34
2025
Q2
$807K Buy
1,036
+90
+10% +$69.9K 0.46% 25
2025
Q1
$782K Sell
946
-14
-1% -$11.6K 0.48% 22
2024
Q4
$741K Buy
+960
New +$795K 0.46% 22

Other funds holding LLY

Chokshi & Queen Wealth Advisors's LLY Position: Q2 2026 in Review

Chokshi & Queen Wealth Advisors increased its Eli Lilly (LLY) stake by 37% in Q2 2026, buying an estimated $286K and bringing the position to 1,045 shares worth $1.25M. The position accounts for 0.58% of the portfolio, ranked #21.

Chokshi & Queen Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chokshi & Queen Wealth Advisors held 1,045 shares of Eli Lilly worth $1.25M as of Q2 2026.
  • Chokshi & Queen Wealth Advisors bought 280 Eli Lilly shares in Q2 2026, an estimated $286K.
  • Eli Lilly made up 0.58% of Chokshi & Queen Wealth Advisors's portfolio in Q2 2026, its #21 holding.
  • Chokshi & Queen Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chokshi & Queen Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.